Previous 10 | Next 10 |
2023-08-14 10:30:05 ET CV Sciences press release ( OTCQB:CVSI ): Q2 GAAP EPS of -$0.01. Revenue of $4M (-3.4% Y/Y). For further details see: CV Sciences GAAP EPS of -$0.01, revenue of $4M
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results PR Newswire SAN DIEGO , Aug. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp e...
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023 PR Newswire SAN DIEGO , Aug. 1, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company sp...
CV Sciences to Participate in LD Micro Invitational Conference PR Newswire 13th invitational event welcomes over 150 companies to over 800 attendees SAN DIEGO , June 1, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Scienc...
2023-05-15 12:09:10 ET CV Sciences, Inc. (CVSI) Q1 2023 Earnings Conference Call May 15, 2023, 10:00 AM ET Company Participants Joseph Dowling - CEO, Secretary and Director Joerg Grasser - CFO Conference Call Participants Presentation Operator ...
2023-05-15 09:07:45 ET CV Sciences press release ( OTCQB:CVSI ): Q1 Non-GAAP EPS of $0.00. Revenue of $4.15M (-6.7% Y/Y). For further details see: CV Sciences Non-GAAP EPS of $0.00, revenue of $4.15M
CV Sciences, Inc. Reports First Quarter 2023 Financial Results PR Newswire SAN DIEGO , May 15, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex...
CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023 PR Newswire SAN DIEGO , May 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company special...
CV Sciences, Inc. Introduces New THC Offering PR Newswire +PlusCBD™ Reserve Collection Extra Gummies provide easy-to-dose 5mg THC option SAN DIEGO , April 3, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Scien...
2023-03-29 13:32:06 ET CV Sciences, Inc. (CVSI) Q4 2022 Earnings Call Transcript March 29, 2023 10:00 AM Company Participants Joseph Dowling - CEO, Secretary and Director Joerg Grasser - CFO Conference Call Participants Presentation Operator ...
News, Short Squeeze, Breakout and More Instantly...
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024 PR Newswire SAN DIEGO , May 8, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company special...
Hemp-focused CV Sciences, Inc. (OTCQB:CVSI) announced its financial results on Thursday for the year ended Dec. 31, 2023. The San Diego-based compa...